SEC Filing Summary

Gregory Russotti, Chief Technology and Manufacturing Officer at Century Therapeutics, Inc., reported a sale of 2,587 shares of Common Stock on September 14, 2026. The transaction, coded as 'S', resulted in a disposal of shares with a price of $1.93 per share. Following this transaction, Mr. Russotti directly owns 509,198 shares. Additionally, the filing indicates that 92,773 shares are held indirectly by the Gregory Russotti 2021 Family Trust. The sale was to cover tax withholding obligations associated with the vesting of restricted stock units and was automatic, not at the discretion of the reporting person.